Raymond James & Associates DICERNA PHARMACEUTICALS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
N/A
-22,207 Closed
0 $0
Q3 2021

Nov 02, 2021
SELL
N/A
-13,628 Reduced 38.03%
22,207 $448,000
Q2 2021

Aug 11, 2021
BUY
N/A
6,563 Added 22.42%
35,835 $1.34 Million
Q1 2021

May 14, 2021
BUY
N/A
7,148 Added 32.31%
29,272 $748,000
Q4 2020

Feb 12, 2021
SELL
N/A
-371 Reduced 1.65%
22,124 $487,000
Q3 2020

Nov 04, 2020
BUY
N/A
17 Added 0.08%
22,495 $405,000
Q2 2020

Jul 28, 2020
SELL
N/A
-155 Reduced 0.68%
22,478 $571,000
Q1 2020

Apr 21, 2020
SELL
N/A
-1,978 Reduced 8.04%
22,633 $416,000
Q4 2019

Feb 12, 2020
BUY
N/A
165 Added 0.67%
24,611 $542,000
Q3 2019

Nov 07, 2019
BUY
N/A
24,446 New
24,446 $351,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email